Leksell gamma knife radiosurgery for cerebral arteriovenous malformations in pediatric patients

Antonio Nicolato1, Roberto Foroni, Andrea Seghedoni

  • 1Department of Neurosurgery, University Hospital, Piazzale Stefani 1, Verona, Italy. antonio.nicolato@mail.azosp.vr.it

Insights

Gamma knife radiosurgery (GKR) effectively treats pediatric cerebral arteriovenous malformations (cAVMs), achieving high obliteration rates with minimal permanent complications. This study supports GKR as a safe and beneficial treatment option for children.

Area of Science:

  • Neurosurgery
  • Radiation Oncology
  • Pediatric Neurology

Background:

  • Pediatric cerebral arteriovenous malformations (cAVMs) pose significant risks, including hemorrhage.
  • Traditional treatment options for cAVMs can be associated with considerable morbidity.
  • Gamma knife radiosurgery (GKR) has emerged as a less invasive therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy and safety of Gamma Knife radiosurgery (GKR) for pediatric cerebral arteriovenous malformations (cAVMs).
  • To assess the complication rates, obliteration rates, and long-term outcomes of GKR in a pediatric population.
  • To discuss the advantages, risks, and failures associated with GKR for cAVMs.

Main Methods:

  • Retrospective analysis of 63 pediatric patients (< or =16 years) treated with GKR for cAVMs.
  • Analysis included patient demographics, cAVM characteristics (volume, Spetzler-Martin grade, location), and clinical presentation (hemorrhage in 50/63).
  • Follow-up included clinical assessment and serial angiography to determine obliteration rates and complications.

Main Results:

  • Complete cAVM occlusion was achieved in 31 out of 39 children with >36-month follow-up (72% at 3 years, 77% at 4 years).
  • GKR-related complications occurred in 2 out of 47 cases with follow-up (1 transient, 1 permanent morbidity).
  • No bleeding events were observed during the latency period following GKR treatment.

Conclusions:

  • Gamma knife radiosurgery demonstrates a high rate of complete obliteration for pediatric cAVMs.
  • The treatment is associated with a very low frequency of permanent morbidity and no intra-latency bleeding.
  • GKR is a safe and effective therapeutic option for pediatric cAVMs, encouraging its widespread application.
Abstract

Related Concept Videos